PGR and neoplasm: In the concentration range between 1.7 and 3.4 μg ml−1 approximately two-fold higher concentrations of paclitaxel are required for PR positive/T-stage 3 or 4 tumours to achieve a toxicity similar to that as for PR-negative/T-stage 1 or 2 tumours.